1. Amos CI, Bali D, Thiel TJ, Anderson JP, Gourley I, Frazier MI, Lynch PM, Luchtefeld MA, Young A, McGarrity TJ, and Seldin MF (1997). Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. Cancer Res.. 57: 3653–3656.
2.
2. Beamer WG (1986). Gonadotropin, steroid, and thyroid hormone milieu of young SWR mice bearing spontaneous granulosa cell tumors. J. Nail. Cancer Inst.. 77: 1117–1123.
3.
3. Beamer WG, Hoppe PC, and Whitten WK (1985). Spontaneous malignant granulosa cell tumors in ovaries of young SWR mice. Cancer Res.. 45: 5575–5581.
4.
4. Beamer WG, Shultz KL, and Tcnnent BJ (1988). Induction of ovarian granulosa cell tumors in SWXJ-9 mice with dehydroepiandros-terone. Cancer Res.. 48: 2788–2792.
5.
5. Beamer WG, Shultz KL, Tennent BJ, Nadeau JH, and Eicher EM (1997). Multigenic and imprinting control of ovarian granulosa cell tumors in mice. Cancer Res. (in press).
6.
6. Beamer WG, Shultz KL, Tennent BJ, and Shultz LD (1993). Granulosa cell tumorigenesis in genetically hypogonadal-immunodefi-cient mice grafted with ovaries from tumor susceptible donors. Cancer Res.. 53: 3741–3746.
7.
7. Beamer WG, Tennent BJ, Shultz KL, Shultz LD, Nadeau JD, and Skow LC (1988). Gene for ovarian granulosa cell tumor susceptibility, Get, in SWXJ recombinant inbred strains of mice revealed by dehydroepiandrostcrone. Cancer Res.. 48: 5092–5095.
8.
8. Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, and Tamimi HK (1997). Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol. Oncol.. 64: 64–69.
9.
9. Chada S, Comelisse CJ, and Sellaberg M (1990). Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors. Gynecol. Oncol.. 36: 240–245.
10.
10. Evans AE, D'Angio GJ, and Snyder H (1987). Selecting initial therapy for pediatric genitourinary cancers. Cancer. 60: 480–489.
11.
11. Evans MP, Webb MJ, Gaffey TA, Katzman JA, Stunan VJ, and Hu TC (1995). DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients. Cancer. 75: 2295–2298.
12.
12. Fishel S and Jakson P (1989). Follicular stimulation for high tech pregnancies: Are we playing it safe? Br Med J.. 299: 309–311.
13.
13. Fletcher J A, Gibas Z, Donovan K, Perez-Atayde A, Genest D, Morton CC, and Lage JM (1991). Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am. J. Pathol.. 138: 515–520.
14.
14. Fox H (1985). Sex cord-stromal tumours of the ovary. J. Pathol.. 145: 127–148.
15.
15. Friedman CI, Lams JD, Schweizer FW, and Kim MH (1981). Hormonal screenings of hyperestrogenic, elderly, obese females for a granulosa cell tumor. J. Reprod. Med.. 26: 268–271.
16.
16. Gocze PM, Beamer WG, Dc Jong FH, and Freeman DA (1997). Hormone synthesis and responsiveness of spontaneous granulosa cell tumors in (SWR X SWXJ-9)F, mice. Gynecol. Oncol.. 65: 143–148.
17.
17. Graves PE, Surwit EA, Davis JR, and Stouffer RL (1985). Adenylate cyclase in human ovarian cancers: Sensitivity to gonadotropins and nonhormonal activators. Am. J. Obstet. Gynecol.. 153: 887–882.
18.
18. Gustafson ML, Lee MM, Asmundson L, MacLaughlin DT, and Donahoe PK (1993). Mullerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. J. Pediatr. Surg.. 28: 439–444.
19.
19. Hahlin M, Crona N, Knutsson F, and Janson PO (1991). Human granulosa cell tumor: Stimulation of steroidogenesis by gonadotropins in vitro. Gynecol. Oncol.40: 201–206.
20.
20. Halpcrin D, Visscher DW, Wallis T, and Lawrence WD (1995). Evaluation of chromosome 12 copy number in ovarian granulosa cell tumors using interphase cytogenetics. Int. J. Gynecol. Pathol.. 14: 319–323.
21.
21. Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, Knuutila A, Salovaara R, Bodmer W, Shibata D, de la Chapelle A, and Aaltonen LA (1997). Localization of a susceptibility locus for Puetz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat. Genet.. 15: 87–90.
22.
22. Hitchcock CL, Norris HJ, Khalifa MA, and Wargotz ES (1989). Flow cytometric analysis of granulosa cell tumors. Cancer. 64: 2127–2132.
23.
23. Kammerman S, Demopoulos R, Raphael C, and Ross J (1981). Gonadotropic hormone binding to human ovarian tumors. Hum. Pathol.. 10: 886–890.
24.
24. Klemi PJ, Joensuu H, and Salmi T (1990). Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary. Cancer. 65: 1189–1193.
25.
25. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, and de Bruijn HWA (1989). Inhibin as a marker for granulosa cell tumors. N. Engl. J. Med.. 321: 790–793.
26.
26. Lee NC, Wingo PA, Gwinn ML, Rubin GL.Kendrick JS, Webster LA, and Ory HW (1987). The reduction in risk of ovarian cancer associated with oral-contraceptive use. N. Engl. J. Med.. 316: 650–655.
27.
27. Lyons J, Landis CA, Harsh G, and Vallar L (1990). Two G protein oncogenes in human endocrine tumors. Science. 249: 655–659.
28.
28. Murphy ED (1972). Hyperplastic and early neoplastic changes in the ovaries of mice after genie deletion of germ cells. J. Natl. Cancer Inst.. 48: 1283–1295.
29.
29. Nakano R, Kitayama S, Yamoto M, Shima K, and Ooshima A (1989). Localization of gonadotropin binding sites in human ovarian neoplasms. Am. J. Obstet. Gynecol.. 161: 905–910.
30.
30. Nishida M, Jimi S, Haji M, Kai T, and Tasaka H (1991). Juvenile granulosa cell tumor in association with a high serum inhibin level. Gynecol. Oncol.. 40: 90–94.
31.
31. Norris HJ and Jensen RD (1972). Relative frequency of ovarian neoplasms in children and adolescents. Cancer. 30: 713–719.
32.
32. Ohel G, Kaneti H, and Schenker JG (1983). Granulosa cell tumors in Israel: A study of 172 cases. Gynecol. Oncol.. 15: 278–286.
33.
33. Persons DL, Hartmann LC, Herath JF, Keeney GL, and Jenkins RB (1994). Fluorescence in situhybridization analysis of trisomy 12 in ovarian tumors. Am. J. Clin. Pathol.. 102: 775–777.
34.
34. Piquettc GN, Kenney RM, Sertich PL, Yamoto M, and Hsuch AJW (1990). Equine granulosa-theca cell tumors express inhibin a- and Pa-subunit messenger ribonucleic acids and proteins. Biol. Reprod.. 43: 1050–1057.
35.
35. Rajaniemi H, Kauppila A, Ronneberg L, Selander K, and Pystynen P (1981). LH (hCG) receptor in benign and malignant tumors of human ovary. Ada Obstet. Gynecol. Scand. Suppl.. 101: 83–86.
36.
36. Rossing MA, Daling JR, Weiss NS, Moore DE, and Self SG (1994). Ovarian tumors in a cohort of infertile women. N. Engl. J. Med.. 331: 771–776.
37.
37. Roth LM, Nicholas TL, and Ehrlich CE (1979). Juvenile granulosa cell tumor. Cancer. 44: 2194–2205.
38.
38. Sasano H, Mason JI, Sasaki E, Yajima A, Kimura N, Namiki T, Sasano N, and Nagura H (1990). Immunohistochemical study of 3p-hydroxysteroid dehydrogenase in sex cord-stromal tumors of the ovary. Int. J. Gynecol. Pathol.. 9: 352–362.
39.
39. Sasano H, Okamoto M, Maison JI, Simpson ER, Mendelson CR, Sasano N, and Silverberg SG (1989). Immunohistochemical studies of steroidogenic enzymes (aromatase, 17a-hydroxylase, and cholesterol side-chain cleavage cytochromes P450) in sex cord-stromal tumors of the ovary. Hum. Pathol.. 20: 452–457.
40.
40. Schofield DE and Fletcher J A (1992). Trisomy 12 in pediatric granulosa-stromal cell tumors. Am. J. Pathol.. 141: 1265–1269.
41.
41. Scully RE (1977). Ovarian tumors. A review. Am. J. Pathol.. 87: 686–720.
42.
42. Serov SF, Scully RE, and Sobin LH (1973). Histological Typing of Ovarian Tumours.World Health Organization, Geneva.
43.
43. Shen Y, Manners P, Jobling T, Burger HG, and Fuller PJ (1996). Absence of the previously reported G protein oncogene (gip2)in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab.. 81: 4159–4161.
44.
44. Shultz KL, Svenson KL, Cheah YC, Paigen B, and Beamer WG (1996). Strain distribution pattern for SSLP markers in the SWXJ recombinant inbred strain set: Chromosomes 7 to X. Mamm. Genome. 7: 526–532.
45.
45. Silverman LA and Gitelman SE (1996). Immunoreactive inhibin, mullerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors. J. Pediatr.. 129: 918–921.
46.
46. Spinas R, Kaufman SC, and Alexander NJ (1993). Fertility drugs and ovarian cancer: Red alert or red herring? Fertil. Steril.. 59: 291–292.
47.
47. Stouffer RL, Grodin MS, Davis JR, and Surwit EA (1984). Investigation of binding sites or follicle stimulating hormone and chorionic gonadotropin in human ovarian cancers. J. Clin. Endocrinol. Metab.. 59: 441–446.
48.
48. Svenson KL, Cheah YC, Shultz KL, Mu JL, Paigen B, and Beamer WG (1995). Strain distribution pattern for the SSLP markers in the SWXJ recombinant inbred strain set: Chromosomes 1 to 6. Mamm. Genome. 6: 867–872.
49.
49. Swanson SA, Norris HJ, Kelsten MI, and Wheeler JE (1990). DNA content of juvenile granulosa cell tumors determine by flow cytometry. Int. J. Gynecol Pathol. 9: 101–109.
50.
50. Tcnnent BJ, Beamer WG.Shultz LD, and Adamson ED (1989). Epidermal growth factor receptors in spontaneous ovarian granulosa cell tumors of SWR-derived mice. Int. J. Cancer. 44: 477–482.
51.
51. Tennent BJ, Shultz KL, and Beamer WG (1993). Genetic susceptibility for C19 androgen induction of ovarian granulosa cell tu-morigenesis in SWXJ strains of mice. Cancer Res.. 53: 1059–1063.
52.
52. Tennent BJ, Shultz KL, Sundberg JP, and Beamer WG (1990). Preneoplastic, primary, and metastatic ovarian granulosa cell tumors in a novel SWR-derived F, hybrid mouse stock. Am. J. Obstet. Gynecol.. 163: 625–634.
53.
53. Wentz AC and McCranie WM (1976). Circulating hormone levels in a case of granulosa cell tumor. Ferlil. Steril. 27: 167–170.
54.
54. Wilson SJ, Young BK, Katz M, Kammerman S, Epstein J, and Bigelow B (1980). A gonadotropin responsive virilizing granulosa cell tumor. Diagn. Gynecol. Obstet.. 2: 275–281.
55.
55. Young RH, Dickersin GR, and Scully RE (1984). Juvenile granulosa cell tumor of the ovary. Am. J. Surg. Pathol. 8: 575–596.
56.
56. Young RH, Lawrence WD, and Scully RE (1985). Juvenile granulosa cell tumorAnother neoplasm associated with abnormal chromosomes and ambiguous genitalia. Am. J. Surg. Pathol. 9: 737–743.
57.
57. Young RH, Welch WR, Dickersin GR, and Scully RE (1982). Ovarian sex cord tumor with annular tubules. Cancer. 50: 1384–1402.